Stocks · Health care · Pharmaceutical Preparations

MANNKIND CORP

MNKD Clue Score45
United States Fiscal year ends December CIK 0000899460 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

13 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Michael Castagna
Chief Executive Officer
—
—
—
2,433,779
$8.01M
+10.4%
Stuart A Tross
Chief People & Workpl Officer
—
—
—
1,058,142
$3.48M
+2.6%
David Thomson
EVP Genl Counsel & Secretary
—
—
—
797,554
$2.62M
−3.9%
Steven B. Binder
Director
—
—
—
713,258
$2.35M
−33.7%
Sanjay R Singh
EVP Technical Operations
—
—
—
478,966
$1.58M
+23.6%
Burkhard Blank
EVP Chief Medical Officer
—
—
—
460,791
$1.52M
−5.2%
Lauren M Sabella
EVP Operations
—
—
—
349,841
$1.15M
−7.5%
Dominic Marasco
Pres, Endocrine Business Unit
—
—
—
343,398
$1.13M
+6,610%
Christopher B Prentiss
Chief Financial Officer
—
—
—
318,668
$1.05M
+32.4%
Ajay Ahuja
Chief Medical Officer
—
—
—
318,200
$1.05M
—
Anthony C Hooper
Director
—
—
—
236,153
$776.94K
+34.1%
Ronald J Consiglio
Director
—
—
—
132,342
$435.41K
+8.2%
James Samuel Shannon
Director
—
—
—
64,635
$212.65K
+22.8%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.